跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,648 条关于
“HXN-1002”
全部
5,648
临床试验
4,109
药物
992
机构
8
资讯
539
3天前
Earendil Labs and Genentech Sign Bispecific Antibody Collaboration Worth More Than $1.5 Billion
5个月前
Earendil Labs Initiates Phase IIa Trial of Half-Life Extended Anti-TL1A Antibody HXN-1001 for Ulcerative Colitis
2年前
Capricor Therapeutics Gains FDA Alignment on HOPE-3 Trial Design for CAP-1002 in Duchenne Muscular Dystrophy
2年前
CAP-1002 Shows Promise in Preserving Limb and Heart Function in DMD Patients
2年前
HOPE-3 Trial of CAP-1002 for Duchenne Muscular Dystrophy to Proceed Following Positive Futility Analysis
9个月前
AskBio's Gene Therapies AB-1005 and AB-1002 Receive Japan's Pioneering Regenerative Medical Product Designation
11个月前
Arcadia Medicine Receives FDA Clearance for Novel Non-Racemic MDMA Compound AM-1002
3年前
CAP-1002 Shows Sustained Cardiac Benefit in Duchenne Muscular Dystrophy
2年前
Capricor's CAP-1002 Shows Sustained Benefits in Duchenne Muscular Dystrophy After 3 Years
11个月前
Arcadia Medicine Receives FDA Approval for Clinical Trials of Safer MDMA Formulation AM-1002
第 1 页,共 54 页
上一页
下一页